Search company, investor...

About Vedant

Vedant Incorporated, founded in 1989, is a privately held, U.S.-based corporation headquartered in Newburyport, MA. Vedant's business focus is the continued innovation of unparalleled testing solutions for today's heterogeneous IT environments, with a specific emphasis on automated testing of clinical healthcare systems.

Headquarters Location

26 Parker Street

Newburyport, Massachusetts, 01950,

United States

978-462-0737

Loading...

Loading...

Latest Vedant News

Hot Stocks: Brokerages on Vedant Fashion, Nazara Technologies, Piramal Enterprises and Zee Entertainment

Nov 10, 2023

Hot Stocks: Brokerages on Vedant Fashion, Nazara Technologies, Piramal Enterprises and Zee Entertainment We have collated a list of recommendations from top brokerage firms from ETNow and other sources: Morgan Stanley on Vedant Fashion: Overweight| Target Rs 1418 Morgan Stanley maintained an overweight rating on Vedant Fashion at a target price of Rs 1418. The global investment bank believes that the share price will rise relative to the country index over the next 60 days. The global investment bank expects the company to deliver strong H2 top-line growth, aided by a higher number of wedding dates and festive season. The management has seen good traction in sales, footfalls, and conversions during the Navratri period. Analysis of credit card spend also indicates that festive spending is strong. Improving top-line growth momentum will also drive an improvement in margins. Jefferies on Nazara Technologies: Hold| Target Rs 770 Jefferies downgraded Nazara Technologies to hold from buy and also slashed the target price to Rs 770 from Rs 810 earlier. The company reported soft revenue growth and better margins. E-sports is going strong, but Adtech has disappointed. There are profitability pressures in RMG. A worsening outlook along with a 23% stock rise in the past 3 months leaves limited upside. Jefferies on Piramal Enterprises: Underperform| Target Rs 855 Jefferies maintained an underperform rating on Piramal Enterprises but slashed the target to Rs 855 from Rs 920 earlier. Strong growth in retail while growth in unsecured loans moderates. There is a slight miss in the net interest income (NII). Recoveries and FLDG gains boost other income. The company reported stable asset quality, and the credit cost surprise is negative. CLSA on Zee Entertainment: Buy| Target Rs 300 CLSA maintained a buy rating on Zee Entertainment with a target price of Rs 300. The 2QFY24 revenue was ahead of expectations. Soft ad environment, Zee Studio’s blockbuster, and lower OTT/ZEE5 losses. Zee Sony’s merger is something that investors will watch out for. (Disclaimer: Recommendations, suggestions, views, and opinions given by experts are their own. These do not represent the views of the Economic Times)

Vedant Frequently Asked Questions (FAQ)

  • Where is Vedant's headquarters?

    Vedant's headquarters is located at 26 Parker Street, Newburyport.

  • Who are Vedant's competitors?

    Competitors of Vedant include Beckman Coulter and 4 more.

Loading...

Compare Vedant to Competitors

Covalent Metrology Logo
Covalent Metrology

Covalent Metrology is dedicated to improving advanced materials R&D through innovation in the metrology services business model. Covalent works with clients to elevate their metrology capabilities, resulting in better data generated in less time and at lower cost. Covalent's Analytical Services unit offers Atomic Force Microscopy (AFM) and Optical Profilometry services. Covalent's Metrology Partners unit offers a suite of services based on client-specific development objectives aimed at improving in-house and external metrology quality, speed and cost.

S
Sensia Biosensing Solutions

April 2004, Sensia spun-off from the technologies developed at the Biosensor Group within the National Microelectronics Centre (CNM) of the Spanish National Research Council (CSIC). Concluding research results and availability of biosensing systems already working at lab level originated the proposal of bringing them into commercialisation, after an initial phase of prototyping and industrialisation. This first idea was supported by Genetrix a young biotech company which is interested in developing biosensors for the characterisation and detection of molecular interactions which are relevant in human pathologies. Dr. Pedro Banda, with experience in the semiconductor industry and biosensor technologies, joined in to get in charge of the project.n

E
Essential Group

Essential Group is a specialty clinical research and patient recruitment service organization.

S
Sequenom Center for Molecular Medicine

Sequenom Center for Molecular Medicine (SCMM) is an molecular pathology laboratory created specifically to support cutting-edge diagnostics, translational research and clinical trials. SCMM is primarily focused on the areas of technology development, women's health and oncology. Based in Grand Rapids, Michigan, SCMM collaborates with Spectrum Health, one of Michigan's largest not-for-profit health systems which annually aims to serve hundreds of thousands of patients, and the Van Andel Research Institute, which aims to offer translational research and bioinformatics expertise with the latest in genomics and proteomics technology.

Velos Logo
Velos

Velos provides software solutions for clinical research management. It offers a software platform with an automated research review and biospecimen management solution for trial administration, financial management, patient tracking, reporting, and many other purposes. The company was founded in 1996 and is based in Fremont, California.

Blaze Systems Logo
Blaze Systems

Blaze Systems is a provider of total LIMS software solutions for the laboratory marketplace.

Loading...

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.